跳至主要内容
临床试验/NCT03395301
NCT03395301Unknown不适用

Coil Hysteroscopic Tubal Occlusion : the Treatment of Hydrosalpinx Before IVF-ET

Wenzhou Medical University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2015年12月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
Pregnancy rate

研究概览

简要总结

this study is to investigate the success rate of proximal tubal occlusion with coil devices in women with hydrosalinx and to observe there pregnancy rate with IVF-ET.

详细描述

In this study, investigators will recruit 80 females with unilateral or bilateral hydrosalpinx as confirmed by HSG. Tubal ligation may be a safe and effective method in the treatment of hydrosalpinx. But in this study, investigators will use fiber platinum coils to occlude the tubes. After the treatment, IVF-ET will be applied,and then the patients' pregnancy rate will be assessed in the following-up.

研究设计

研究类型
Interventional
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Have unilateral or bilateral hydrosalpinxs as evidenced by HSG.
  • laparoscopic surgery was considered to be contraindicated because of ex-tensive pelvic adhesions.
  • Are willing to undergo a hysterosalpingogram (HSG) 1 months after fiber platinum coil placement to confirm proximal tubal occlusion.
  • Are willing to participate in this clinical study .Are able to comprehend and give informed consent for participation in this study.
  • Have read, understood and signed an informed consent form .

排除标准

  • Active or recent upper or lower pelvic infection
  • Known hypersensitivity to nickel as confirmed by skin test
  • Known allergy to contrast media Pregnancy or suspected pregnancy
  • Evidence of intrauterine abnormalities such as submucous fibroids, polyps, intrauterine adhesions or presence of a uterine septum
  • Poor general or gynecologic health
  • Inability or refusal to provide informed consent

结局指标

主要结局

Pregnancy rate

时间窗: 2 months after IVF-ET

Patients will be followed up with the pregnancy outcomes after the tubal occlusion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Feng Lin

Associate Chief Physician

First Affiliated Hospital of Wenzhou Medical University

研究点 (1)

Loading locations...

相似试验